Cancer Device Created at Rutgers to See if Targeted Chemotherapy is Working

Artificial intelligence and biosensors can rapidly detect if live cancer cells remain after treatment. Rutgers researchers have created a device that can determine whether targeted chemotherapy drugs are working on individual cancer patients. The portable device, which uses artificial intelligence and biosensors, is up to 95.9 percent accurate in counting live cancer cells when they pass through electrodes, according to a study in the journal Microsystems & Nanoengineering.

“We built a portable platform that can predict whether patients will respond positively to targeted cancer therapy,” said senior author Mehdi Javanmard, an assistant professor in the Department of Electrical and Computer Engineering in the School of Engineering at Rutgers University–New Brunswick.“ Our technology combines artificial intelligence and sophisticated biosensors that handle tiny amounts of fluids to see if cancer cells are sensitive or resistant to chemotherapy drugs.”

Read the full article at Rutgers Today https://news.rutgers.edu/cancer-device-created-rutgers-see-if-targeted-c...